First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML

NCT04840784 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped The reasons for early termination is due to slow recruitment

Conditions

Interventions

Sponsor

Shengke Pharmaceuticals Pty Ltd